Skip to main content
Not Found
Digital Seminar

COVID-19 Treatments

FDA Approved & Off Label Medications

Speaker:
Karen Morrissey, PhD, FNP, BC
Duration:
1 Hour 59 Minutes
Format:
Audio and Video
Copyright:
Mar 25, 2022
Product Code:
POS078436
Media Type:
Digital Seminar

Choose a price item

Description

Karen Morrissey PhD, FNP, BC works as a telemedicine family nurse practitioner in a COVID-19 Initiative, delivering care to many patients experiencing COVID symptoms. As guidance continually evolves, this session will cover the latest effective treatment options regarding:

  • Patient self-assessment
  • Risk group priority tiers
  • FDA approved treatments
  • Off label treatments

Credit

Speaker

Karen Morrissey, PhD, FNP, BC's Profile

Karen Morrissey, PhD, FNP, BC Related seminars and products


Karen Morrissey, PhD, FNP, BC, works as a telemedicine family nurse practitioner in a COVID-19 Initiative, delivering care to many patients experiencing COVID symptoms. She brings a wealth of experiences, drawing from roles in PACU, home care, pre-op and correctional nursing. Karen earned her FNP degree from the University of Connecticut and her PhD in Nursing from Walden University.


Speaker Disclosures:
Financial: Karen Morrissey has employment relationships with CVS Minute Clinic and Post University. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Karen Morrissey is a member of the American Association of Nurse Practitioners.


Additional Info

Questions?

Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info


Access for Self-Study Program (Non-Interactive)

You will have access to this product for 12 months from the date of purchase.


Objectives

  1. Assess severity of symptoms to develop the most appropriate plan of care.
  2. Evaluate current FDA approved COVID treatments for use in outpatient clinics.
  3. Analyze non-FDA approved medications and understand why they are not yet approved.
  4. Determine outpatient treatments that should be avoided.

Outline

As guidance continually evolves, learn from a real time discussion on the latest effective treatment options:
  • Patient self-assessment 
  • Symptom rating
  • Risk group priority tiers
  • FDA approved treatments by symptom
  • Off label treatments
  • Tixagevimab-Cigavimab Evusheld
  • Monoclonal antibody therapy
  • Casiriviman/imdevimab
  • Sotrovimab
  • Bamlaniviman-etesevimab
  • Remdesivir veklury
  • Nirmatrelvir-ritonavir Paxlovid
  • Molnupiravir
  • Outpatient therapies that should be avoided

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physicians
  • Physicians Assistants

Reviews

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to: PO Box 1000, Eau Claire, WI 54702-1000 or call 1-800-844-8260.

ADA Needs
We would be happy to accommodate your ADA needs; please call our Customer Service Department for more information at 1-800-844-8260.

PESI Mobile App

Access CE trainings on your phone or tablet through our free mobile app. Choose video or audio-only versions of online courses from the world’s best instructors, and complete your CE requirements anywhere, anytime, at your own pace.

https://cdn.pesi23.com/images/android.png     https://cdn.pesi23.com/images/iphone.png

Please wait ...

Back to Top